跳至主要内容
临床试验/CTRI/2019/05/019168
CTRI/2019/05/019168已完成2 期

A clinical study to compare the antihypertensive benefits of Cilnidipine & Azilsartan in T2DM patients. - not applicable

Dr SHAMEEMUNISHA0 个研究点目标入组 64 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients with Type 2 Diabetes Mellitus > 2years duration on medical treatment with newly diagnosed Simple Hypertension (JNC8)
  • 2.Male and Female
  • 3.Age >40 years
  • 4.Outpatient from Department of General Medicine.
  • 5.BMI up to type I obesity (30-40)
  • 6.All DM patients on OHA either single /double/triple/insulin

排除标准

  • 1.Renal dysfunction,
  • 2.Patients on NSAIDS, STATIN, ASPIRIN, Immunomodulators , alternative medicines
  • 3.Hepatic dysfunction
  • 4.Cardiac abnormalities
  • 5.Pregnancy and lactating women
  • 6.Inpatients
  • 7.ICU patients
  • 8.EMD patients
  • 9.Serious infections
  • 11.H/o Smoking,Alcohol

研究者

发起方
Dr SHAMEEMUNISHA

相似试验